GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vista Pharmaceuticals Ltd (BOM:524711) » Definitions » Median PS Value

Vista Pharmaceuticals (BOM:524711) Median PS Value : ₹5.72 (As of May. 30, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Vista Pharmaceuticals Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Vista Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1.822. Vista Pharmaceuticals's 10-Year median PS Ratio is 3.1394. Therefore, the Median PS Value for today is ₹5.72.

As of today (2024-05-30), Vista Pharmaceuticals's share price is ₹13.39. Vista Pharmaceuticals's Median PS Value is ₹5.72. Therefore, Vista Pharmaceuticals's Price to Median PS Value for today is 2.34.

The historical rank and industry rank for Vista Pharmaceuticals's Median PS Value or its related term are showing as below:

BOM:524711' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 2.15   Med: 16.08   Max: 115.86
Current: 2.34

During the past 13 years, the highest Price to Median PS Value of Vista Pharmaceuticals was 115.86. The lowest was 2.15. And the median was 16.08.

BOM:524711's Price-to-Median-PS-Value is ranked worse than
93.29% of 507 companies
in the Drug Manufacturers industry
Industry Median: 0.82 vs BOM:524711: 2.34

Vista Pharmaceuticals Median PS Value Historical Data

The historical data trend for Vista Pharmaceuticals's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vista Pharmaceuticals Median PS Value Chart

Vista Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.24 0.52

Vista Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.52 1.80 4.32 5.72

Competitive Comparison of Vista Pharmaceuticals's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, Vista Pharmaceuticals's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vista Pharmaceuticals's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vista Pharmaceuticals's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Vista Pharmaceuticals's Price-to-Median-PS-Value falls into.



Vista Pharmaceuticals Median PS Value Calculation

Vista Pharmaceuticals's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1.822*3.1394
=5.72

10-Year Median PS Ratio is 3.1394.
Vista Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1.822.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vista Pharmaceuticals  (BOM:524711) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Vista Pharmaceuticals's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=13.39/5.72
=2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vista Pharmaceuticals Median PS Value Related Terms

Thank you for viewing the detailed overview of Vista Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Vista Pharmaceuticals (BOM:524711) Business Description

Traded in Other Exchanges
N/A
Address
Plot No. 104, Kakateeya Hills, Ravindra Co OP Society Guttala Begumpet, Hyderabad, TG, IND, 500033
Vista Pharmaceuticals Ltd is an Indian based company engaged in single operating segments that is the manufacturing of Pharmaceutical products. The company offers over the counter and prescription generic drug products such as tablets, capsules, and liquids covering various therapeutic categories. Some of the drugs in tablet dosage forms are Sulfamethoxazole and Trimethoprim, Bismuth Subgallate, Pyrantel Pamoate, Aspirin, Ibuprofen, Ranitidine HCl, and others. Nifedipine, Piroxicam, Indomethacin are the drugs offered by the company in a capsule dosage form. The business is carried out in India.

Vista Pharmaceuticals (BOM:524711) Headlines

No Headlines